Overt hepatic encephalopathy, or HE, is a common complication of cirrhosis. Up to 40% of patients with cirrhosis will develop HE within their disease course. As such, it represents significant emotional and socioeconomic burden for patients, their families and caregivers. ⁽¹’²⁾
Key healthcare professionals in the field of liver decompensation and HE have identified a strong need to collaborate across all sectors in order to improve patient management and outcomes in this field.
This multidisciplinary webinar will present three perspectives from specialists all interacting with HE patients at certain stages of the management pathway. Our expert speakers will present their views on how healthcare professionals can work together to develop strategies to lessen the burden of HE.
Discussion will include the importance of effective and standardised long-term management, a nurse’s perspective on practical care, and recent advances in this field including new data from King’s College London discussing management techniques for patients on the transplant list.
Register now to become part of a synergistic team working to improve outcomes in HE and to educate nurses, patients and caregivers whilst developing the necessary tools to facilitate effective long-term management strategies for HE.
1. Shawcross et al. Eur J Gastroenterol Hepatol. 2016 Feb; 28(2): 146–152.
2. Bajaj et al. Am J Gastroenterol. 2011 Sep; 106(9): 1646–1653.
GL/XIF/1017/0176e
Date of preparation November 2017
Dr Jasmohan Bajaj, MD, PhD,
Associate Professor - Department of Internal Medicine, Virginia Commonwealth University, USA
Active in research, Dr Bajaj has served as a principal or co-investigator for numerous clinical trials in hepatic encephalopathy, chronic liver disease and microbiome. He is an Associate Editor for the American Journal of Gastroenterology and Journal of Clinical and Experimental Hepatology and is on the editorial board for Journal of Hepatology and Liver Transplantation. Dr Bajaj is the Chairperson for the North American Consortium for Study of End-stage Liver Disease and is the President of the International Society for Hepatic Encephalopathy and Nitrogen Metabolism.
Dr Debbie Shawcross, MD, PhD,
Senior Lecturer and Clinician Scientist - Institute of Liver Studies, King’s College London, UK
Dr Shawcross has always had a specific interest in education and teaching. She is the lead for Education and Training in Hepatology within King’s Health Partners Academic Health Sciences Centre and the Training Programme Director for Gastroenterology and Hepatology Specialist Training in South Thames. She also leads on undergraduate teaching in the Institute of Liver Studies and is a Medical School Clinical Advisor.
Rikke Baltzer, RN, BsNC,
Specialist Nurse - Hepato-gastroenterology Department, Aarhus University Hospital, Denmark
Rikke joined Aarhus University Hospital in 2005 and earned her qualifications with extensive training in HE treatment and care. She is the co-founder of the Danish Network of Hepatology Nurses and has been a member of the steering committee since 2011. Rikke considers liver patients to be some of the most challenging and complex patients to work with. It is her mission to increase awareness of HE and to educate nurses, patients and caregivers whilst developing the necessary tools to facilitate effective long-term management strategies for HE.
- Understand how different roles within the HE management pathway can work together with a multidisciplinary approach to optimise outcome
- Be informed of recently published data in the field of HE and the implications of these data for clinical practice
- Any interested parties
- Gastroenterologist
- Hepatologist
- Transplant Surgeon
- Internal Medicine
- Nurse
- Doctor
- Medical Research Officer
- Support Worker
- Patient
- Chronic Liver Disease Specialists
- Hepatic Encephalopathy Specialist
- Professor
- Associate Professor
- Dietitian
- Nurse Mangers
- Service Managers
- Medical students
